EPC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Edgewell Personal Care Co (EPC) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. While the stock has shown some positive price movement recently and analysts have slightly raised price targets, the financial performance remains weak with negative net income and declining gross margins. Additionally, there are no strong technical or proprietary trading signals to support immediate action. Holding off for now is the most prudent choice.
The MACD is positive but contracting, indicating a lack of strong momentum. RSI is in the neutral zone at 74.306, and moving averages are converging, suggesting no clear trend. The stock is trading near its resistance level of 22.78, with the next resistance at 23.259 and support at 21.229.
Analysts have slightly raised price targets, with Wells Fargo increasing its target to $24 and maintaining an Overweight rating. The company's portfolio has improved following the divestiture of its Feminine Care business.
The company's financial performance is weak, with a negative net income of -$65.7 million and a significant drop in gross margin (-5.08% YoY). There is no recent news or significant insider or hedge fund activity to indicate strong interest in the stock.
In Q1 2026, revenue increased by 1.85% YoY to $422.8 million. However, net income remains negative at -$65.7 million, albeit with a significant improvement of 3028.57% YoY. EPS improved to -1.41, up 3425.00% YoY, but gross margin declined to 39.45%, down -5.08% YoY.
Analysts have shown mixed sentiment. Wells Fargo raised its price target to $24, citing an improved portfolio and maintaining an Overweight rating. Barclays raised its target to $21 but kept an Equal Weight rating, noting that results were largely in line with expectations after removing noise from divestitures.
